Arcutis Biotherapeutics Share Price (NASDAQ: ARQT)
$15.51
▲
0.02
(0.13%)
Last updated on
Check the interactive Arcutis Biotherapeutics Stock chart to analyse performance
Arcutis Biotherapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$15.10Today's High:$15.57
2.64%
Downside
Day's Volatility :3.02%
Upside
0.39%
- 52 Weeks Low:$8.0352 Weeks High:$17.75
48.23%
Downside
52 Weeks Volatility :54.76%
Upside
12.62%
Arcutis Biotherapeutics Stock Returns
Arcutis Biotherapeutics Inc Key Stats
Check Arcutis Biotherapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Arcutis Biotherapeutics Stock including INR - Dollar returns
The Arcutis Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Arcutis Biotherapeutics investment value today
Current value as on today
₹1,52,998
Returns
₹52,998
(+53%)
Returns from Arcutis Biotherapeutics Stock
₹47,714 (+47.71%)
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Arcutis Biotherapeutics Stock
Global Institutional Holdings in Arcutis Biotherapeutics Inc
Name
Holdings %
Suvretta Capital Management, LLC
9.62%
Jennison Associates LLC
9.27%
Rubric Capital Management LP
8.97%
BlackRock Inc
7.42%
Vanguard Group Inc
5.88%
Polar Capital Holdings PLC
5.59%
Analyst Recommendation on Arcutis Biotherapeutics Stock
Buy
76%Buy
23%Hold
0%Sell
Based on 13 Wall street analysts offering stock ratings for Arcutis Biotherapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Arcutis Biotherapeutics Share Price Target
What analysts predicted
Upside of 40.92%
Target:
$21.86
Current:
$15.51
Arcutis Biotherapeutics share price target is $21.86, a slight Upside of 40.92% compared to current price of $15.51 as per analysts' prediction.
Arcutis Biotherapeutics Stock Insights
Price Movement
In the last 1 year, ARQT stock has moved up by 42.6%Increasing Revenue
Revenue is up for the last 2 quarters, 65.84M → 81.50M (in $), with an average increase of 19.2% per quarterIncreasing Net Profit
Netprofit is up for the last 2 quarters, -25.06M → -15.88M (in $), with an average increase of 57.8% per quarterARQT vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 27.3%ARQT vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 152.5%Price to Sales
ForARQT every $1 of sales, investors are willing to pay $7.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Arcutis Biotherapeutics Technicals Summary
Sell
Neutral
Buy
Arcutis Biotherapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Arcutis Biotherapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 6.41% | 20.93% | 47.76% | -42.26% | -37.44% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -0.46 | -0.57 | -0.13 | NA | 1.16 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $1.9B | -37.44% | NA | -35.4% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Arcutis Biotherapeutics Inc
Key Management of Arcutis Biotherapeutics Inc
Important FAQs about investing in ARQT Stock from India :
What is Arcutis Biotherapeutics share price today?
Arcutis Biotherapeutics share price today is $15.51 as on at the close of the market. Arcutis Biotherapeutics share today touched a day high of $15.57 and a low of $15.10.
What is the 52 week high and 52 week low for Arcutis Biotherapeutics share?
Arcutis Biotherapeutics share touched a 52 week high of $17.75 and a 52 week low of $8.03. Arcutis Biotherapeutics stock price today i.e. is closed at $15.51, lower by 12.62% versus the 52 week high.
How to invest in Arcutis Biotherapeutics Stock (ARQT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Arcutis Biotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arcutis Biotherapeutics Shares that will get you 0.0967 shares as per Arcutis Biotherapeutics share price of $15.51 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Arcutis Biotherapeutics Stock (ARQT) from India?
Indian investors can start investing in Arcutis Biotherapeutics (ARQT) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Arcutis Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Arcutis Biotherapeutics share’s latest price of $15.51 as on August 30, 2025 at 1:29 am IST, you will get 0.6447 shares of Arcutis Biotherapeutics. Learn more about
fractional shares .
What are the returns that Arcutis Biotherapeutics has given to Indian investors in the last 5 years?
Arcutis Biotherapeutics stock has given -37.44% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%